NeoGenomics, Inc. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
NeoGenomics, Inc. (NEO) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $44.72 million for the 12-month period ending 2015-12-31, per its 10-K filed 2018-03-13.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2018-03-13
- NeoGenomics, Inc. adjustments to additional paid in capital, convertible debt with conversion feature for fiscal 2015 was $44.72M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 12 month |
|---|---|
| 2015-12-31 | $44.72M 10-K · filed 2018-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |